Related references
Note: Only part of the references are listed.Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia
Benshang Li et al.
BLOOD (2020)
A Novel Pathogenic Variant in the N-Terminal Domain of the Glucocorticoid Receptor, Causing Glucocorticoid Resistance
Rosa Maria Paragliola et al.
MOLECULAR DIAGNOSIS & THERAPY (2020)
Haploinsufficiency of NR3C1 drives glucocorticoid resistance in adult acute lymphoblastic leukemia cells by down-regulating the mitochondrial apoptosis axis, and is sensitive to Bcl-2 blockage
Haowen Xiao et al.
CANCER CELL INTERNATIONAL (2019)
New attempts for central nervous infiltration of pediatric acute lymphoblastic leukemia
Fen Zhou et al.
CANCER AND METASTASIS REVIEWS (2019)
Functional Characterization of Glucocorticoid Receptor Variants Is Required to Avoid Misinterpretation of NGS Data
Loic Foussier et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2019)
Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: BIM Finally
Jessie A. Brown et al.
CANCER CELL (2018)
Global efforts toward the cure of childhood acute lymphoblastic leukaemia
Ching-Hon Pui et al.
LANCET CHILD & ADOLESCENT HEALTH (2018)
Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients
Blanca Scheijen et al.
HAEMATOLOGICA (2017)
Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients
Blanca Scheijen et al.
HAEMATOLOGICA (2017)
New targeted therapies for relapsed pediatric acute lymphoblastic leukemia
Joanna Pierro et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia
Valentina Serafin et al.
BLOOD (2017)
Tumor suppressor IKZF1 mediates glucocorticoid resistance in B-cell precursor acute lymphoblastic leukemia
R. Marke et al.
LEUKEMIA (2016)
VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research
Zhongwu Lai et al.
NUCLEIC ACIDS RESEARCH (2016)
Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia
Koichi Oshima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells
Steven W. Paugh et al.
NATURE GENETICS (2015)
Acute Lymphoblastic Leukemia in Children
Stephen P. Hunger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Loss of TBL1XR1 Disrupts Glucocorticoid Receptor Recruitment to Chromatin and Results in Glucocorticoid Resistance in a B-Lymphoblastic Leukemia Model
Courtney L. Jones et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Exploring the Molecular Mechanisms of Glucocorticoid Receptor Action from Sensitivity to Resistance
Sivapriya Ramamoorthy et al.
HORMONE RESISTANCE AND HYPERSENSITIVITY: FROM GENETICS TO CLINICAL MANAGEMENT (2013)
DELLY: structural variant discovery by integrated paired-end and split-read analysis
Tobias Rausch et al.
BIOINFORMATICS (2012)
The Pediatric Cancer Genome Project
James R. Downing et al.
NATURE GENETICS (2012)
CREBBP mutations in relapsed acute lymphoblastic leukaemia
Charles G. Mullighan et al.
NATURE (2011)
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2011)
Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone
Seoyeon Choi et al.
BLOOD (2007)
Share Paper
